Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Antibiotics (Basel, Switzerland)
|
April 28, 2023
Sulfonamidoboronic Acids as "Cross-Class" Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in <i>Acinetobacter baumannii</i>
Maria Luisa Introvigne, Trevor J Beardsley, Micah C Fernando, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2025
NF-κB dependent gene expression and plasma IL-1β, TNFα and GCSF drive transcriptomic diversity and CD4:CD8 ratio in people with HIV on ART
Yingfan Wang, German G Gornalusse, David A Siegel, et al.
Open Forum Infectious Diseases
|
October 14, 2017
A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant <i>Enterobacteriaceae</i>
Oryan Henig, Eric Cober, Sandra S Richter, et al.
Journal of Medicinal Chemistry
|
April 10, 2018
Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234
Krisztina M Papp-Wallace, Nhu Q Nguyen, Michael R Jacobs, et al.
Journal of Medicinal Chemistry
|
June 26, 2023
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits <i>Acinetobacter</i>-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum
Rachel A Powers, Cynthia M June, Micah C Fernando, et al.
Open Forum Infectious Diseases
|
January 12, 2019
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant <i>Enterobacteriaceae</i>
Courtney L Luterbach, Ashley Boshe, Heather I Henderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 13, 2016
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality
Laura J Rojas, Madiha Salim, Eric Cober, et al.
Antimicrobial Agents and Chemotherapy
|
May 7, 2014
Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network
David van Duin, Federico Perez, Susan D Rudin, et al.
Antimicrobial Agents and Chemotherapy
|
September 13, 2017
Nosocomial Outbreak of Extensively Drug-Resistant Acinetobacter baumannii Isolates Containing <i>bla</i><sub>OXA-237</sub> Carried on a Plasmid
Andrea M Hujer, Paul G Higgins, Susan D Rudin, et al.
Antimicrobial Agents and Chemotherapy
|
March 11, 2020
ARGONAUT II Study of the <i>In Vitro</i> Activity of Plazomicin against Carbapenemase-Producing Klebsiella pneumoniae
Michael R Jacobs, Caryn E Good, Andrea M Hujer, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Antibiotics (Basel, Switzerland)
|
April 28, 2023
Sulfonamidoboronic Acids as "Cross-Class" Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in <i>Acinetobacter baumannii</i>
Maria Luisa Introvigne, Trevor J Beardsley, Micah C Fernando, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2025
NF-κB dependent gene expression and plasma IL-1β, TNFα and GCSF drive transcriptomic diversity and CD4:CD8 ratio in people with HIV on ART
Yingfan Wang, German G Gornalusse, David A Siegel, et al.
Open Forum Infectious Diseases
|
October 14, 2017
A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant <i>Enterobacteriaceae</i>
Oryan Henig, Eric Cober, Sandra S Richter, et al.
Journal of Medicinal Chemistry
|
April 10, 2018
Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234
Krisztina M Papp-Wallace, Nhu Q Nguyen, Michael R Jacobs, et al.
Journal of Medicinal Chemistry
|
June 26, 2023
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits <i>Acinetobacter</i>-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum
Rachel A Powers, Cynthia M June, Micah C Fernando, et al.
Open Forum Infectious Diseases
|
January 12, 2019
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant <i>Enterobacteriaceae</i>
Courtney L Luterbach, Ashley Boshe, Heather I Henderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 13, 2016
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality
Laura J Rojas, Madiha Salim, Eric Cober, et al.
Antimicrobial Agents and Chemotherapy
|
May 7, 2014
Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network
David van Duin, Federico Perez, Susan D Rudin, et al.
Antimicrobial Agents and Chemotherapy
|
September 13, 2017
Nosocomial Outbreak of Extensively Drug-Resistant Acinetobacter baumannii Isolates Containing <i>bla</i><sub>OXA-237</sub> Carried on a Plasmid
Andrea M Hujer, Paul G Higgins, Susan D Rudin, et al.
Antimicrobial Agents and Chemotherapy
|
March 11, 2020
ARGONAUT II Study of the <i>In Vitro</i> Activity of Plazomicin against Carbapenemase-Producing Klebsiella pneumoniae
Michael R Jacobs, Caryn E Good, Andrea M Hujer, et al.
Page
of 8